Identification of α1-adrenoceptor subtypes involved in contraction of young CD rat epididymal vas deferens

Andersson, 2007, Pharmacology of alpha1-adrenoceptor antagonists in the lower urinary tract and central nervous system, Nat. Clin. Pract. Urol., 4, 368, 10.1038/ncpuro0836 Arunlakshana, 1959, Some quantitative uses of drug antagonists, Br. J. Pharmacol., 14, 48 Bagot, 2006, Alpha1A/L-adrenoceptors mediated contraction of the circular smooth muscle of the pig uretra, Auton. Autocoid Pharmacol., 26, 345, 10.1111/j.1474-8673.2006.00374.x Buckner, 1996, α1-adrenoceptor-induced contractility in rat aorta is mediated by the α1D subtype, Eur. J. Pharmacol., 297, 241, 10.1016/0014-2999(95)00755-5 Bylund, 1994, International Union of Pharmacology Nomenclature of Adrenoceptors, Pharmacol. Rev., 46, 121 Caine, 1978, A placebo-controlled double blind study of the effect of phenoxybenzamine in benign prostatic obstruction, Br. J. Urol., 50, 551, 10.1111/j.1464-410X.1978.tb06210.x Chiu, 2007, (Phenylpiperidinyl)cyclohexylsulfonamides: development of alpha1A/1D-selective adrenergic receptor antagonists for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms (BPH/LUTS), Bioorg. Med. Chem. Lett., 17, 3930, 10.1016/j.bmcl.2007.04.098 Daniels, 1999, Human cloned α1A-adrenoceptor isoforms display α1L-adrenoceptor pharmacology in functional studies, Eur. J. Pharmacol., 370, 337, 10.1016/S0014-2999(99)00154-5 Deng, 1996, Characterization of α1D-adrenoceptor subtype in rat myocardium, aorta and other tissues, Br. J. Pharmacol., 119, 269, 10.1111/j.1476-5381.1996.tb15981.x Eltze, 1991, Vasodilatation elicited by 5-HT1A receptor agonist in constant-pressure-perfused rat kidney is mediated by blockade of α1A-adrenoceptors, Eur. J. Pharmacol., 202, 33, 10.1016/0014-2999(91)90250-T Foglar, 1995, Use of recombinant alpha-1 adrenoceptors to characterize subtype selectivity of drugs for the treatment of prostatic hypertrophy, Eur. J. Pharmacol., 288, 201, 10.1016/0922-4106(95)90195-7 Ford, 1996, Mol. Pharmacol., 49, 209 Ford, 1997, Pharmacological pleiotropism of the human recombinant α1A-adrenoceptor: Implications for α1-adrenoceptor classification, Br. J. Pharmacol., 121, 1127, 10.1038/sj.bjp.0701207 Garg, 2007, Treatment of benign prostate hyperplasia and its management, Indian Pharm., 6, 25 Giardinà, 1995, Synthesis and α-adrenoceptor blocking properties of phenoxybenzamine-related (2-chloroethyl)-(2,3-dihydrobenzo-[1,4] dioxin-2-ylmethyl)-(2-phenoxyethyl) amines, Bioorg. Med. Chem., 3, 85, 10.1016/0968-0896(94)00150-2 Giardinà, 1996, Synthesis and biological profile of the enantiomers of [4-(4-amino-6,7-dimethoxyquinazolin-2-yl)-cis-octahydroquinoxalin-1-yl]furan-2-ylmethanone (cyclazosin), a potent competitive α1B-adrenoceptor antagonist, J. Med. Chem., 39, 4602, 10.1021/jm960510x Giardinà, 2002, Structure-activity relationships among novel phenoxybenzamine-related β-chloroethylamines, Bioorg. Med. Chem., 10, 1291, 10.1016/S0968-0896(01)00395-9 Gu, 2004, Effects of α1-adrenergic receptor subtype selective antagonists on lower urinary tract function in rats with bladder outlet obstruction, J. Urol., 172, 758, 10.1097/01.ju.0000131609.96301.e6 Hagues, 2003, α1-Adrenergic receptor subtypes: non-identical triplets with different dancing partners?, Life Sci., 74, 411, 10.1016/j.lfs.2003.07.008 Hancock, 2002, Preclinical pharmacology of fiduxosin, a novel alpha1-adrenoceptor antagonist with uroselective properties, J. Pharmacol. Exp. Ther., 300, 478, 10.1124/jpet.300.2.478 Hieble, 1995, Alpha and beta-adrenoceptors: from the gene to the clinic. Part 1. Molecular biology and adrenoceptor subclassification, J. Med. Chem., 38, 3415, 10.1021/jm00018a001 Hirasawa, 1995, Cloning, functional expression and tissue distribution of human alpha 1c-adrenoceptor splice variants, FEBS Lett., 363, 256, 10.1016/0014-5793(95)00330-C Kava, 1998, α1L-Adrenoceptor mediation of smooth muscle contraction in rabbit bladder neck: a model for lower urinary tract tissues of man, Br. J. Pharmacol., 123, 1359, 10.1038/sj.bjp.0701748 Ko, 1994, (−)-Discretamine, a selective α1D-adrenoceptor antagonist, isolated from Fissistigma glaucescens, Br. J. Pharmacol., 12, 1174, 10.1111/j.1476-5381.1994.tb13207.x Marshall, 1996, Different subtypes of α1A-adrenoceptor mediating contraction of rat epididymal vas deferens, rat hepatic portal vein and human prostate distinguished by the antagonist RS17053, Br. J. Pharmacol., 119, 407, 10.1111/j.1476-5381.1996.tb16001.x Marucci, 2005, (+)-Cyclazosin, a selective α1B-adrenoceptor antagonist: functional evaluation in rat and rabbit tissues, Eur. J. Pharmacol., 522, 100, 10.1016/j.ejphar.2005.08.044 Muramatsu, 1995, Functional subclassification of vascular alpha1 adrenoceptors, Pharmacol. Commun., 6, 23 Romics, 2007, The role of alpha-adrenoceptors in the treatment of urological diseases, Neurochem. Int., 51, 328, 10.1016/j.neuint.2007.05.023 Ruffolo, 1991, Structure and function of alpha-adrenoceptors, Pharmacol. Rev., 43, 475 Schwinn, 2004, Alpha1-adrenoceptor subtype selectivity and lower urinary tract symptoms, Mayo Clin. Proc., 79, 1423, 10.4065/79.11.1423 Tallarida, 1979, pA2 and receptor differentiation: a statistical analysis of competitive antagonism, Life Sci., 25, 637, 10.1016/0024-3205(79)90505-8 van Rossum, 1963, Cumulative dose–response curves, Arch. Int. Pharmacodyn., 143, 299 Yono, 2008, Region and age dependent differences in α1-adrenergic responsiveness of rat seminal vesicle and vas deferens, Eur. J. Pharmacol., 587, 291, 10.1016/j.ejphar.2008.04.009